Follicular Lymphoma Market Set to Grow at 6.8% CAGR Through 2036 Amid Expanding Pipeline Therapies
Follicular Lymphoma Overview Follicular lymphoma, an indolent B-cell non-Hodgkin’s lymphoma arising from germinal center B cells, continues to represent one of the most prevalent indolent NHL subtypes, accounting for nearly a quarter of all NHL diagnoses. According to DelveInsight’s latest market assessment,